Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Deloitte
AstraZeneca
Julphar
McKinsey
US Army
Merck
Cipla
Daiichi Sankyo

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,545,040

« Back to Dashboard

Summary for Patent: 6,545,040
Title: Method of lowering the blood pressure
Abstract:A method of potentiating the effects of blood pressure reducing agents in warm-blooded animals, said method comprising administering to said warm-blooded animals of an effective amount of a blood pressure reducing agent and a 2,2'-iminobisethanol derivative.
Inventor(s): Xhonneux; Raymond Mathieu (Vlimmeren, BE), Van Lommen; Guy Rosalia Eugene (Berlaar, BE)
Assignee: Janssen Pharmaceutica N.V. (BE)
Application Number:07/825,488
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 6,545,040

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Forest Labs BYSTOLIC nebivolol hydrochloride TABLET;ORAL 021742-002 Dec 17, 2007 RX Yes No ➤ Subscribe ➤ Subscribe Y TREATMENT OF HYPERTENSION ➤ Subscribe
Forest Labs BYSTOLIC nebivolol hydrochloride TABLET;ORAL 021742-003 Dec 17, 2007 RX Yes No ➤ Subscribe ➤ Subscribe Y TREATMENT OF HYPERTENSION ➤ Subscribe
Forest Labs BYSTOLIC nebivolol hydrochloride TABLET;ORAL 021742-004 Dec 17, 2007 RX Yes No ➤ Subscribe ➤ Subscribe Y TREATMENT OF HYPERTENSION ➤ Subscribe
Forest Labs BYSTOLIC nebivolol hydrochloride TABLET;ORAL 021742-005 Oct 8, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y TREATMENT OF HYPERTENSION ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,545,040

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Greece 3006972 ➤ Subscribe
European Patent Office 0334429 ➤ Subscribe SPC/GB96/048 United Kingdom ➤ Subscribe
European Patent Office 0334429 ➤ Subscribe C950031 Netherlands ➤ Subscribe
European Patent Office 0334429 ➤ Subscribe 97C0002 Belgium ➤ Subscribe
Spain 2052881 ➤ Subscribe
Japan H01283220 ➤ Subscribe
Israel 89691 ➤ Subscribe
Ireland 62159 ➤ Subscribe
Ireland 890906 ➤ Subscribe
Hungary 211539 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
US Department of Justice
Julphar
QuintilesIMS
Accenture
McKesson
Teva
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot